Literature DB >> 4385052

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.

G Bartholini, M Da Prada, A Pletscher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4385052     DOI： 10.1111/j.2042-7158.1968.tb09726.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN： 0022-3573            Impact factor:   3.765


× No keyword cloud information.
  29 in total

1.  The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.

Authors:  H Altier; M Moldes; J M Monti
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

2.  Discrimination of monoamine uptake by membranes of adrenal chromaffin granules.

Authors:  M Da Prada; R Obrist; A Pletscher
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

3.  Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.

Authors:  U Strömberg; B Waldeck
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

Review 4.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

5.  [Sleep in patients with Parkinson's disease and its influence by L-DOPA (author's transl)].

Authors:  E Schneider; H Maxion; B Ziegler; P Jacobi
Journal:  J Neurol       Date:  1974-06-27       Impact factor: 4.849

6.  On the relationship between L-DOPA therapy and CSF monoamine metabolites in Parkinson's disease.

Authors:  C Casati; A Agnoli; A Jori; E Dolfini
Journal:  Z Neurol       Date:  1973-04-02

Review 7.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

8.  Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor.

Authors:  U K Rinne; V Sonninen; T Sirtola
Journal:  Z Neurol       Date:  1972

9.  On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine).

Authors:  J G Christenson; W Dairman; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

10.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.